Nicole Sandford was appointed President and Chief Executive Officer in February 2022 after serving as a member of the company's Board since February 2021.
Nicole brings more than three decades of executive and leadership experience to the role. Nicole has extensive experience as an innovator and business leader as well as a sought-after advisor to CEOs and Boards on strategy, operations, human capital, governance, and risk. At global consultancy Deloitte, Nicole was the executive sponsor of multiple new businesses in the life sciences/healthcare, financial services, and consumer industries where she consistently oversaw rapid, sustainable growth.
Prior to joining Aspira, Nicole was the Global Board Services Leader for boutique human capital advisory and search firm, Ellig Group, where she advised multiple Fortune 500 companies. Prior to that, she spent 27+ years with global consultancy Deloitte, launching and leading all aspects of operations for multiple businesses. Her last role was US managing partner of Deloitte Risk and Financial Advisory LLP’s Regulatory and Operational Risk business. Previously, she was a Deloitte & Touche LLP audit partner, specializing in high-growth global companies in the technology, healthcare, and industrial sectors. She has extensive experience with complex transactions including mergers and acquisitions, financing, and both private and public securities offerings.
Nicole is an Emeritus Member of the Weinberg Center at the University of Delaware and the patient representative for the Greenwich Hospital Breast Cancer Accreditation Committee. She is the Board Chair of Girl Scouts of Connecticut and a Board Member of the Stamford Public Education foundation. Nicole has received the Yale School of Management’s “Rising Star” Award and The International Alliance for Women (TIAW) World of Difference 100 Award. She holds a Bachelor of Business Administration (with honors) from Niagara University.